Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

An epistatic interaction between the PAX8 and STK17B genes in papillary thyroid cancer susceptibility.

Landa I, Boullosa C, Inglada-Pérez L, Sastre-Perona A, Pastor S, Velázquez A, Mancikova V, Ruiz-Llorente S, Schiavi F, Marcos R, Malats N, Opocher G, Diaz-Uriarte R, Santisteban P, Valencia A, Robledo M.

PLoS One. 2013 Sep 23;8(9):e74765. doi: 10.1371/journal.pone.0074765. eCollection 2013. Erratum in: PLoS One. 2013;8(10). doi:10.1371/annotation/cd94c3eb-70f2-4dfa-85be-b3fc41e495c3.

PMID:
24086368
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF-mutant thyroid carcinomas.

Montero-Conde C, Ruiz-Llorente S, Dominguez JM, Knauf JA, Viale A, Sherman EJ, Ryder M, Ghossein RA, Rosen N, Fagin JA.

Cancer Discov. 2013 May;3(5):520-33. doi: 10.1158/2159-8290.CD-12-0531. Epub 2013 Jan 29.

PMID:
23365119
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Alpha-lipoic acid induces sodium iodide symporter expression in TPC-1 thyroid cancer cell line.

Choi HJ, Kim TY, Ruiz-Llorente S, Jeon MJ, Han JM, Kim WG, Shong YK, Kim WB.

Nucl Med Biol. 2012 Nov;39(8):1275-80. doi: 10.1016/j.nucmedbio.2012.08.007. Epub 2012 Sep 18.

PMID:
22995901
[PubMed - indexed for MEDLINE]
4.

Genome-wide analysis of Pax8 binding provides new insights into thyroid functions.

Ruiz-Llorente S, Carrillo Santa de Pau E, Sastre-Perona A, Montero-Conde C, Gómez-López G, Fagin JA, Valencia A, Pisano DG, Santisteban P.

BMC Genomics. 2012 Apr 24;13:147. doi: 10.1186/1471-2164-13-147.

PMID:
22531031
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors.

Landa I, Ruiz-Llorente S, Montero-Conde C, Inglada-Pérez L, Schiavi F, Leskelä S, Pita G, Milne R, Maravall J, Ramos I, Andía V, Rodríguez-Poyo P, Jara-Albarrán A, Meoro A, del Peso C, Arribas L, Iglesias P, Caballero J, Serrano J, Picó A, Pomares F, Giménez G, López-Mondéjar P, Castello R, Merante-Boschin I, Pelizzo MR, Mauricio D, Opocher G, Rodríguez-Antona C, González-Neira A, Matías-Guiu X, Santisteban P, Robledo M.

PLoS Genet. 2009 Sep;5(9):e1000637. doi: 10.1371/journal.pgen.1000637. Epub 2009 Sep 4.

PMID:
19730683
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Association study of 69 genes in the ret pathway identifies low-penetrance loci in sporadic medullary thyroid carcinoma.

Ruiz-Llorente S, Montero-Conde C, Milne RL, Moya CM, Cebrián A, Letón R, Cascón A, Mercadillo F, Landa I, Borrego S, Pérez de Nanclares G, Alvarez-Escolá C, Díaz-Pérez JA, Carracedo A, Urioste M, González-Neira A, Benítez J, Santisteban P, Dopazo J, Ponder BA, Robledo M; Medullary Thyroid Carcinoma Clinical Group.

Cancer Res. 2007 Oct 1;67(19):9561-7.

PMID:
17909067
[PubMed - indexed for MEDLINE]
Free Article
7.

Loss of the actin regulator HSPC300 results in clear cell renal cell carcinoma protection in Von Hippel-Lindau patients.

Cascón A, Escobar B, Montero-Conde C, Rodríguez-Antona C, Ruiz-Llorente S, Osorio A, Mercadillo F, Letón R, Campos JM, García-Sagredo JM, Benítez J, Malumbres M, Robledo M.

Hum Mutat. 2007 Jun;28(6):613-21.

PMID:
17311301
[PubMed - indexed for MEDLINE]
8.

Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: a possible hot spot?

Cascón A, Montero-Conde C, Ruiz-Llorente S, Mercadillo F, Letón R, Rodríguez-Antona C, Martínez-Delgado B, Delgado M, Díez A, Rovira A, Díaz JA, Robledo M.

Genes Chromosomes Cancer. 2006 Mar;45(3):213-9.

PMID:
16258955
[PubMed - indexed for MEDLINE]
9.

Succinate dehydrogenase D variants do not constitute a risk factor for developing C cell hyperplasia or sporadic medullary thyroid carcinoma.

Cascon A, Cebrian A, Pollan M, Ruiz-Llorente S, Montero-Conde C, Leton R, Gutierrez R, Lesueur F, Milne RL, Gonzalez-Albarran O, Lucas-Morante T, Benitez J, Ponder BA, Robledo M.

J Clin Endocrinol Metab. 2005 Apr;90(4):2127-30. Epub 2004 Dec 28.

PMID:
15623805
[PubMed - indexed for MEDLINE]
10.

A novel candidate region linked to development of both pheochromocytoma and head/neck paraganglioma.

Cascón A, Ruiz-Llorente S, Rodríguez-Perales S, Honrado E, Martínez-Ramírez A, Letón R, Montero-Conde C, Benítez J, Dopazo J, Cigudosa JC, Robledo M.

Genes Chromosomes Cancer. 2005 Mar;42(3):260-8.

PMID:
15609347
[PubMed - indexed for MEDLINE]
11.

PupaSNP Finder: a web tool for finding SNPs with putative effect at transcriptional level.

Conde L, Vaquerizas JM, Santoyo J, Al-Shahrour F, Ruiz-Llorente S, Robledo M, Dopazo J.

Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W242-8.

PMID:
15215388
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The RET IVS1-126G>T variant is strongly associated with the development of sporadic medullary thyroid cancer.

Fernandez RM, Robledo M, Antinolo G, Pecina A, Ruiz-Llorente S, Eng C, Borrego S.

Thyroid. 2004 Apr;14(4):329-31. No abstract available.

PMID:
15142370
[PubMed - indexed for MEDLINE]
13.

Genetic and epigenetic profile of sporadic pheochromocytomas.

Cascon A, Ruiz-Llorente S, Fraga MF, Leton R, Telleria D, Sastre J, Diez JJ, Martinez Diaz-Guerra G, Diaz Perez JA, Benitez J, Esteller M, Robledo M.

J Med Genet. 2004 Mar;41(3):e30. No abstract available.

PMID:
14985401
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Genetic characterization and structural analysis of VHL Spanish families to define genotype-phenotype correlations.

Ruiz-Llorente S, Bravo J, Cebrián A, Cascón A, Pollan M, Tellería D, Letón R, Urioste M, Rodríguez-López R, de Campos JM, Muñoz MJ, Lacambra C, Benítez J, Robledo M.

Hum Mutat. 2004 Feb;23(2):160-9.

PMID:
14722919
[PubMed - indexed for MEDLINE]
15.

Mutational and gross deletion study of the MEN1 gene and correlation with clinical features in Spanish patients.

Cebrián A, Ruiz-Llorente S, Cascón A, Pollán M, Díez JJ, Picó A, Tellería D, Benítez J, Robledo M.

J Med Genet. 2003 May;40(5):e72. No abstract available.

PMID:
12746426
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

G12S and H50R variations are polymorphisms in the SDHD gene.

Cascón A, Ruiz-Llorente S, Cebrián A, Letón R, Tellería D, Benítez J, Robledo M.

Genes Chromosomes Cancer. 2003 Jun;37(2):220-1. No abstract available.

PMID:
12696072
[PubMed - indexed for MEDLINE]
17.

Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1).

Meléndez B, Rodríguez-Perales S, Martínez-Delgado B, Otero I, Robledo M, Martínez-Ramírez A, Ruiz-Llorente S, Urioste M, Cigudosa JC, Benítez J.

Hum Genet. 2003 Feb;112(2):178-85. Epub 2002 Nov 13.

PMID:
12522559
[PubMed - indexed for MEDLINE]
18.

SDHB mutation analysis in familial and sporadic phaeochromocytoma identifies a novel mutation.

Cascón A, Cebrián A, Ruiz-Llorente S, Tellería D, Benítez J, Robledo M.

J Med Genet. 2002 Oct;39(10):E64. No abstract available.

PMID:
12362046
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

A rapid and easy method for multiple endocrine neoplasia type 1 mutation detection using conformation-sensitive gel electrophoresis.

Arancha C, Ruíz-Llorente S, Cascón A, Osorio A, Martínez-Delgado B, Benítez J, Robledo M.

J Hum Genet. 2002;47(4):190-5.

PMID:
12166655
[PubMed - indexed for MEDLINE]
20.

Identification of novel SDHD mutations in patients with phaeochromocytoma and/or paraganglioma.

Cascon A, Ruiz-Llorente S, Cebrian A, Telleria D, Rivero JC, Diez JJ, Lopez-Ibarra PJ, Jaunsolo MA, Benitez J, Robledo M.

Eur J Hum Genet. 2002 Aug;10(8):457-61.

PMID:
12111639
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk